BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24099521)

  • 1. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.
    Pfeifer A; Wojtas B; Oczko-Wojciechowska M; Kukulska A; Czarniecka A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Rusinek D; Tyszkiewicz T; Kowal M; Jarzab M; Hauptmann S; Lange D; Paschke R; Jarzab B
    BMC Med Genomics; 2013 Oct; 6():38. PubMed ID: 24099521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of formalin-fixed, paraffin-embedded follicular thyroid carcinoma samples from patients who developed postoperative distant metastasis.
    Jikuzono T; Ishikawa T; Hirokawa M; Sugitani I; Ishibashi O
    BMC Res Notes; 2020 May; 13(1):241. PubMed ID: 32404135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of suspicious thyroid nodules using four protein biomarkers.
    Cerutti JM; Latini FR; Nakabashi C; Delcelo R; Andrade VP; Amadei MJ; Maciel RM; Hojaij FC; Hollis D; Shoemaker J; Riggins GJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3311-8. PubMed ID: 16740752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
    Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
    Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasonic identification and regression analysis of 294 thyroid follicular tumors.
    Ou D; Yao J; Jin J; Yan M; Shi K; Zheng Q; Yang C; Xu D
    J Cancer Res Ther; 2020 Sep; 16(5):1056-1062. PubMed ID: 33004747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling.
    Wojtaś B; Pfeifer A; Jarząb M; Czarniecka A; Krajewska J; Swierniak M; Stokowy T; Rusinek D; Kowal M; Zebracka-Gala J; Tyszkiewicz T; Oczko-Wojciechowska M; Stobiecka E; Lange D; Paschke R; Jarząb B
    Endokrynol Pol; 2013; 64(5):328-34. PubMed ID: 24186587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
    Cerutti JM; Delcelo R; Amadei MJ; Nakabashi C; Maciel RM; Peterson B; Shoemaker J; Riggins GJ
    J Clin Invest; 2004 Apr; 113(8):1234-42. PubMed ID: 15085203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation markers differentiate thyroid cancer from benign nodules.
    Stephen JK; Chen KM; Merritt J; Chitale D; Divine G; Worsham MJ
    J Endocrinol Invest; 2018 Feb; 41(2):163-170. PubMed ID: 28612287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
    Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
    Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular Thyroid Adenoma and Follicular Thyroid Carcinoma-A Common or Distinct Background? Loss of Heterozygosity in Comprehensive Microarray Study.
    Borowczyk M; Dobosz P; Szczepanek-Parulska E; Budny B; Dębicki S; Filipowicz D; Wrotkowska E; Oszywa M; Verburg FA; Janicka-Jedyńska M; Ziemnicka K; Ruchała M
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
    Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
    Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z
    J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction.
    Yang Y; Liao C; Yang Q; Li Y; Tang Y; Xu B
    World J Surg Oncol; 2023 Nov; 21(1):367. PubMed ID: 38007446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.
    Jikuzono T; Kawamoto M; Yoshitake H; Kikuchi K; Akasu H; Ishikawa H; Hirokawa M; Miyauchi A; Tsuchiya S; Shimizu K; Takizawa T
    Int J Oncol; 2013 Jun; 42(6):1858-68. PubMed ID: 23563786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.